反応式
[F:1][C:2]([F:22])([F:21])[C:3]1[CH:8]=[CH:7][C:6]([C:9]2[CH:10]=[CH:11][C:12]([N:15]3[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]3)=[N:13][CH:14]=2)=[CH:5][CH:4]=1.[Cl:23][CH2:24][C:25]([N:27]([CH3:29])[CH3:28])=[O:26]>>[ClH:23].[CH3:28][N:27]([CH3:29])[C:25](=[O:26])[CH2:24][N:18]1[CH2:19][CH2:20][N:15]([C:12]2[CH:11]=[CH:10][C:9]([C:6]3[CH:5]=[CH:4][C:3]([C:2]([F:1])([F:21])[F:22])=[CH:8][CH:7]=3)=[CH:14][N:13]=2)[CH2:16][CH2:17]1参加物
3
実験手順
The title compound was prepared by a similar procedure to that described in Example 55, starting from 4-(5-(4-trifluoromethylphenyl)pyridin-2-yl)piperazine and 2-chloro-N,N-dimethylacetamide.
出典と根拠
- ORDレコード
- ord-af128aaa1a814d6aaba34bfafaf11f2a
- 出典データセット
- uspto-grants-2014_09
- 特許番号
- US08846677B2
関連ノート
読み込み中…